BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 20012012)

  • 1. Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study.
    DeFronzo RA; Banerji MA; Bray GA; Buchanan TA; Clement S; Henry RR; Kitabchi AE; Mudaliar S; Musi N; Ratner R; Reaven P; Schwenke DC; Stentz FD; Tripathy D;
    Diabetologia; 2010 Mar; 53(3):435-45. PubMed ID: 20012012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].
    Tang XF; Li H; Wang JG; Chu SL; Guo JZ; Zhu DL
    Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):735-9. PubMed ID: 15631823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.
    Retnakaran R; Shen S; Hanley AJ; Vuksan V; Hamilton JK; Zinman B
    Obesity (Silver Spring); 2008 Aug; 16(8):1901-7. PubMed ID: 18551118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
    Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE;
    Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
    Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
    Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
    Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
    Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese.
    Oka R; Yagi K; Sakurai M; Nakamura K; Moriuchi T; Miyamoto S; Nohara A; Kawashiri MA; Takeda Y; Yamagishi M
    Endocr J; 2012; 59(1):55-64. PubMed ID: 22068110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.
    Tripathy D; Carlsson M; Almgren P; Isomaa B; Taskinen MR; Tuomi T; Groop LC
    Diabetes; 2000 Jun; 49(6):975-80. PubMed ID: 10866050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.
    Utzschneider KM; Prigeon RL; Faulenbach MV; Tong J; Carr DB; Boyko EJ; Leonetti DL; McNeely MJ; Fujimoto WY; Kahn SE
    Diabetes Care; 2009 Feb; 32(2):335-41. PubMed ID: 18957530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
    Osei K; Gaillard T; Schuster DP
    Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.
    Hong J; Zhang YF; Gu WQ; Zhang YW; Su YX; Chi ZN; Wang WQ; Li XY; Ning G
    Endocrine; 2008; 34(1-3):75-80. PubMed ID: 18979203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay of insulin resistance and beta-cell dysfunction involves the development of type 2 diabetes in Chinese obeses.
    Hong J; Gu WQ; Zhang YF; Yang YS; Shen CF; Xu M; Li XY; Wang WQ; Ning G
    Endocrine; 2007 Apr; 31(2):93-9. PubMed ID: 17873317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relation between fasting plasma glucose concentrations and insulin resistance].
    Li L; Wang GX; Li P; Shang XJ; Liu C; Wang YJ; Yue GY
    Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):755-8. PubMed ID: 16255885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition index does not reflect β-cell function in IGT subjects treated with pioglitazone.
    DeFronzo RA; Tripathy D; Abdul-Ghani M; Musi N; Gastaldelli A
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3774-81. PubMed ID: 24937535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin sensitivity and pancreatic beta cell function changes during the transformation from normal to impaired glucose tolerance].
    Li J; Yan L; Chen LH; Li Y; Li F; Liu SL; Qi YQ; Cheng H
    Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):842-5. PubMed ID: 18218239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.